Soft Tissue Sarcoma — Trials

Soft Tissue Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

1,383 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 338
Recruiting: 188
Ph III recruiting: 14
Growth YoY: −16.5%
Industry share: 14%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (195)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06171282	A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors	unknown	Early Phase 1	9	Shanghai Yunying Medical TechnologyINDUSTRY	1	Dec 14, 2023	clinicaltrials
NCT06117878	Safety and Efficacy of NK510 to Treat Osteosarcoma and Soft Tissue Sarcoma	unknown	Early Phase 1	12	Base Therapeutics (Shanghai) Co., Ltd.INDUSTRY	1	Nov 7, 2023	clinicaltrials